B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Late Phase of HIV Life Cycle

REACTOME PATHWAY
Reactome: R-HSA-1625998 genes12 compounds

The Late Phase of HIV Life Cycle pathway (Reactome ID: R-HSA-162599) involves 8 genes and is affected by 12 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

CCNT2CDK7CDK9ERCC3FURINRANRNGTTXPO1

Compounds Affecting Late Phase of HIV Life Cycle

#CompoundTargets HitStudies
1hydroxyfasudil [Supplementary Concept]11
2pictilisib25
3Sorafenib300
4plumbagin [Supplementary Concept]300
5oridonin300
6Diminazene300
7silver sulfadiazine299
8alsterpaullone12
9kenpaullone8
10Levamisole299
11Reserpine297
12Tripterygium300

About the Late Phase of HIV Life Cycle Pathway

The Late Phase of HIV Life Cycle pathway is catalogued in Reactome (ID: R-HSA-162599) and involves 8 genes. In the BiohacksAI corpus, 12 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include CCNT2, CDK7, CDK9, ERCC3, FURIN.